# Sutro Biopharma (stock symbol: STRO) Logo in transparent PNG and SVG formats

## Sutro Biopharma Logo large

### Sutro Biopharma Logo large Download PNG (36.48 KB)

![Sutro Biopharma Logo large Download PNG (36.48 KB)](/img/orig/STRO_BIG-644b35bd.png)

### Sutro Biopharma Logo large Download SVG (5.97 KB)

![Sutro Biopharma Logo large Download SVG (5.97 KB)](/img/orig/STRO_BIG-2100ad96.svg)

## Sutro Biopharma Logo icon format

### Sutro Biopharma Logo icon format Download PNG (37.99 KB)

![Sutro Biopharma Logo icon format Download PNG (37.99 KB)](/img/orig/STRO-baaf9275.png)

### Sutro Biopharma Logo icon format Download SVG (1.13 KB)

![Sutro Biopharma Logo icon format Download SVG (1.13 KB)](/img/orig/STRO-0157f83c.svg)

## Sutro Biopharma Logo large for dark backgrounds

### Sutro Biopharma Logo large for dark backgrounds Download PNG (23.13 KB)

![Sutro Biopharma Logo large for dark backgrounds Download PNG (23.13 KB)](/img/orig/STRO_BIG.D-90187863.png)

### Sutro Biopharma Logo large for dark backgrounds Download SVG (5.95 KB)

![Sutro Biopharma Logo large for dark backgrounds Download SVG (5.95 KB)](/img/orig/STRO_BIG.D-a9325dde.svg)

## Sutro Biopharma Logo icon format for dark backgrounds

### Sutro Biopharma Logo icon format for dark backgrounds Download PNG (23.54 KB)

![Sutro Biopharma Logo icon format for dark backgrounds Download PNG (23.54 KB)](/img/orig/STRO.D-d87fde9a.png)

### Sutro Biopharma Logo icon format for dark backgrounds Download SVG (1.1 KB)

![Sutro Biopharma Logo icon format for dark backgrounds Download SVG (1.1 KB)](/img/orig/STRO.D-ba286823.svg)

## About Sutro Biopharma

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.

1. Website domain: sutrobio.com
2. Employees: 259
3. Marketcap: $0.25 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
